EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nature of bacitracin resistance in Staphylococcus aureus

Merianne Mohamad iD, Mollie M Hurst, Elham Elkrewi, Christopher P Randall iD, Alex J O'Neill iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00875-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Merianne Mohamad und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom. Hauptthemen laut MEDLINE: Bacitracin, Anti-Bacterial Agents, Staphylococcus aureus. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacitracin is employed for topical treatment of staphylococcal infection, though information is lacking regarding the nature of resistance to this antibiotic in the staphylococci. Here we examined bacitracin resistance in a large collection ( n = 1,470) of multidrug-resistant isolates of Staphylococcus aureus . Susceptibility testing of the entire collection revealed a broad range of bacitracin minimum inhibitory concentrations (MICs) (from 32 to >4,096 µg/mL) and allowed us to define a tentative epidemiological cut-off value (TECOFF) (apparent upper end of the wild-type distribution in terms of bacitracin susceptibility) of 256 µg/mL. On the basis of this TECOFF, 101 strains (6.8% of the total) for which bacitracin had an MIC of ≥512 µg/mL were considered resistant. Bacitracin resistance was found across multiple sequence types (STs), though over half the resistant strains belonged to the ST8:USA300 lineage. In nearly all bacitracin-resistant strains (99 of 101), whole genome sequence analysis identified operons similar to the bcrABD operon that confers bacitracin resistance in Enterococcus faecalis ; 3 strains carried an operon [ bcrAB (ISL3) D ] closely related to the latter (~90% identity in the encoded resistance proteins), while 96 strains harbored a more distantly related operon (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacitracinAnti-Bacterial AgentsStaphylococcus aureusMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialHumansStaphylococcal InfectionsOperon

Stichwörter der Autor:innen

bacitracinpeptide antibioticresistance determinantssilencing of antibiotic resistance by mutation (SARM)topical antibacterialtriple antibiotic ointment

Substanzen

BacitracinAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

ORCID-Profile: Merianne Mohamad, Christopher P Randall, Alex J O'Neill

Zitieren

APA

Mohamad, M., Hurst, M. M., Elkrewi, E., Randall, C. P., & O'Neill, A. J. (2025). Nature of bacitracin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00875-25

Vancouver

Mohamad M, Hurst MM, Elkrewi E, Randall CP, O'Neill AJ. Nature of bacitracin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00875-25

BibTeX
@article{Mohamad2025,
  author = {Mohamad, Merianne and Hurst, Mollie M and Elkrewi, Elham and Randall, Christopher P and O'Neill, Alex J},
  title = {Nature of bacitracin resistance in Staphylococcus aureus},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00875-25}
}
Kostenlos starten →